dog's tail perfused with saline.
The next step was obvious. The renin solution was mixed with plasma and put through the tail. An intense vasoconstriction occurred.
Since we knew that renin was a protein, it was boiled and mixed with plasma. This mixture was inactive. Similarly, a mixture of renin with boiled plasma caused no constriction. However, when renin and plasma were incubated together, even at room temperature, and boiled and the coagulum centrifuged off, the resulting solution eauLsed a strong constriction of the vessels of the isolated dog's Circulation, Volume XXV, January 1962 tail. The substance in the plasma which reacted with renin we called renin-activator. 1 Soon thereafter, Dr. Page and I reported a new substance formed by the interaction of renin and renin-activator. 2 We called it angiotonin.
Shortly before his untimely death, BraunMenendez, in a lecture at the Indiana University School of Medicine, described the steps which led to the discovery of hypertensin in the Institute of Physiology at the University of Buenos Aires.3 Houssay had become interested in hypertension in 1923. The motivation for this research was the death of one of his most brilliant pupils, who died of malignant hypertension at the age of 33 years. Houssay and Fasciolo, in 1937, were the first to demonstrate that a humoral mechanism was involved in the type of experimental hypertension produced by Goldblatt and his coworkers. They produced hypertension in a dog by Goldblatt's technic and grafted 1 of its kidneys into the neck of a nephrectomized dog. The blood pressure of the latter dog began to rise in a few minutes, and after the elevated pressure was established, it remained at a high level for 2 to 3 hours, even after the removal of the grafted kidney.
Houssay then called Braun-Menendez, Fasciolo, and Leloir, a biochemist, for a conference. He told them, "<Well, here we have a very important observation. Something is poured into the blood by the kidney. This substance we must isolate." As Braun-Menendez remarked, "It was an easy thing to say but not so easy to do. " The experiment which led to their discovery of a substance, which they named hypertensin, was the grafting of a normal kidney into right renal veins of a patient with accelerated hypertension and those from a norinotensive patient. A strong contraction was produced by 0.5 ml. of renal venous plasma from the patient with hypertension, whereas 2.0 ml. of renal venous plasma from the normotensive patient was inactive.
In figure 2 , 5 ml. of brachial artery plasma from the same 2 patients were injected intravenously in a 2-day postnephrectomized cat. The plasma from the hypertensive patient (J.S.) caused a marked elevation in pressure, whereas the plasma from the inormotensive subject (D.W.) showed only a slight change as a result of volume effect. 'With these plasmas, as well as with all others tested, there was a close parallel between the constrictor activity on the aortic strip and the pressor activity in the pithed cat. The contour of the pressure curve of the active plasma differed from that of the angiotensin standard in that the pressure remained above the baseline. This response to plasma may be due to renin in the plasma and its reaction product, angiotensin. Evidence that the enzyme in the plasma had the characteristics of renin and that its reaction product behaved like angiotensin will be presented in the following sections.
Nature of the Vasoactive Factors
The aortic strip is an excellent preparation for working out factors concerned in the formation of the vasoactive agent in plasma. Human renin or renin from other species does not cause a conitraction of the muscle. Furthermuore, renin-substrate and angiotenisin I are inactive on the strip. In figure 3 , a response to dialyzed plasma from a patient with malignant hypertension is compared with that to angiotensin. Sometimies, depending on the sensitivity of the strip and the activity of the plasma, the contour of the response is identical to that with angioteilsin II. However, as in this figure, the delay in shortening often is longer, and the rate of contraction is slower.
In figure 3 , 0.15 of our unit caused a recorded 31 The enzyme kinetics are the same as renini. The optimum activity of the enzyme in dialyzed plasma is approximately pH 5.5. When human plasma was incubated with angiotensin for 1 hour at 37 C. at pH 4.5 to 8.5 in inerenients of 1.0 pH unit, the miaximum inactivation -occurred at pH 7.5. This may partially explain the greater activity of plasma when incubated in vitro at pH 5.5 rather than at pH 7.4. It also behaves like human renin in that its activity is increased tremendously by a rise of reaction temperature from 2 to 37 C.10 The enzyme is of renal origin. It is always found in greater quantity in the renal venous blood than in peripheral blood. Samples of peripheral plasma from patients with unilateral renal vascular disease have a high content of renin. After removal of the involved kidney, the activity of the peripheral plasma showed very low or no demonstrable constrictor activity."
Further evidence for the identity of the enzyme in plasma of hypertensive patients with renin was obtained by incubating an 4active" plasma and an "inactive" plasma for 4 hours at 37 C. at pH 5.5. Any angiotensin formed during the incubation was removed by adsorption on animal charcoal. Before this procedure, the renin-substrate in terms of angiotensin units was 8.4 AU/ml. After the incubation and charcoal treatment, the reninsubstrate was reduced to 6.6 AU/ml.
The vasoactive heat-stable factor liberated by the action of the renin-like enzyme has the following properties which are similar to anigiotenlsin: It has the properties of a polypeptide. It is destroyed, as shown in figure 4 , by incubation with crystalline trypsin and chymotrypsin under the same conditionis as angiotensin. The vasoactive substance is also inactivated by kidney and red cell angiotensinase. These properties, as well as the comparatively short incubation time necessary for its release and its formation when incubation is performed in the presence of ethylenediaminetetra-acetic acid, differentiate it fromn vasopressor lipids found in plasma.12-14 The contour of the pressure curve cannot be differentiated from angiotensin ( fig. 4 ). Other characteristics of this polypeptide which are also identical to angiotensin are the rate of dialysis through "Visking" casings, adsorption on animal charcoal, and elution by glacial acetic acid. Pharmacologically, too, the constrictor activity of dialyzed plasnla on the aortic strip is similar to angiotensin II.
Neither is blocked by phentolamine. Aortic strips which are insensitive to angiotensin II are also insensitive to "active" plasma, even when the strip responds strongly to catechol amines.
The presence of the converting enzyme and the 2 forms of angiotensin can also be demonistrated in the dialyzed plasma of patients with arterial hypertension, as shown in figure   3 . The plasma was dialyzed in a cold room for 4 days with running double-distilled water at 4 C. Aliquots were incubated for 1 hour at 37 C. at pH 5.5, with and without the addition of NaCl, and boiled to stop the reaction. The coagulum was removed by centrifugation and the supernatant assayed for constrictor activity on the aortic strip. The dialyzed plasma incubated without NaCl was inactive like angiotensin I. The sample incubated with NaCl behaved like angiotensin IIL Circulation, Volume XXV, January 1962 I feel that the data presented in this paper demonstrate the presence of renin in the blood of patients with arterial hypertension. By means of kinetic studies based on the reninangiotensin system, it is possible to express the renin content of dialyzed plasma in terms of Goldblatt units per L. For example, the renal venous plasma from the involved kidney of a patient with unilateral kidney disease contained 7.0 Goldblatt units of renin per L. The brachial artery blood, drawn 5 days before, had a value of 1.5 units. These values are compatible with a blood pressure of 200/ 130. Two hours after the removal of the involved kidney, no renin could be detected in the peripheral blood of this patient.
Dr. Judson and I have assayed approximately 400 samples of plasma from patients with arterial hypertension. The highest values for renin are found in accelerated hypertension and in patients with renal vascular occlusive disease. In the latter condition, it has proved quite useful in determining which is the involved kidney. The plasmas of many patients with essential hypertension have an elevated renin content. However, the plasmas from some patients with high pressure are inactive. Since such small amounts of plasma are needed to do the assay, it is hoped that the application of the technics described in this paper will help to clarify the role of renin in arterial hypertension.
